HEPATIC IMPAIRMENT AND HEALTHY FEMALE
Clinical trials for HEPATIC IMPAIRMENT AND HEALTHY FEMALE explained in plain language.
Never miss a new study
Get alerted when new HEPATIC IMPAIRMENT AND HEALTHY FEMALE trials appear
Sign up with your email to follow new studies for HEPATIC IMPAIRMENT AND HEALTHY FEMALE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver function study tests new Drug's safety in 24 volunteers
Knowledge-focused Not yet recruitingThis early-stage study looks at how a single 25 mg dose of VC005 tablets behaves in people with mild or moderate liver impairment compared to healthy volunteers. The goal is to measure drug levels and safety. 24 participants will take one dose and be monitored closely.
Matched conditions: HEPATIC IMPAIRMENT AND HEALTHY FEMALE
Phase: PHASE1 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Liver function and drug levels: a closer look at GS1-144
Knowledge-focused Not yet recruitingThis early-stage study looks at how the drug GS1-144 moves through the bodies of women with and without liver problems. About 24 women aged 18 to 70 will take part. The goal is to measure drug levels and see if liver function affects them. No treatment is being tested.
Matched conditions: HEPATIC IMPAIRMENT AND HEALTHY FEMALE
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC